| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:2619.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia
A New Anatomic Approach for Curing Atrial Fibrillation
From the Department of Cardiology, San Raffaele University Hospital (C.P., S.R., M.T., F.G., G.V., A.S., C.D., P.M., V.S., S.G., S.C.), Milan, Italy, and University of Messina (G.O.), Messina, Italy.
Correspondence to Dr Carlo Pappone, San Raffaele University Hospital, Via Olgettina 60, 20132 Milan, Italy. E-mail carlo.pappone{at}hsr.it
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—The pulmonary veins (PVs) and surrounding ostial areas frequently house focal triggers or reentrant circuits critical to the genesis of atrial fibrillation (AF). We developed an anatomic approach aimed at isolating each PV from the left atrium (LA) by circumferential radiofrequency (RF) lesions around their ostia.
Methods and Results—We
selected 26 patients with resistant AF, either paroxysmal (n=14) or
permanent (n=12). A nonfluoroscopic mapping system was used to generate
3D electroanatomic LA maps and deliver RF energy. Two maps were
acquired during coronary sinus and right atrial pacing to validate the
lateral and septal PV lesions, respectively. Patients were followed up
closely for 
6 months. Procedures lasted 290±58 minutes, including
80±22 minutes for acquisition of all maps, and 118±16 RF pulses were
deployed. Among 14 patients in AF at the beginning of the procedure,
64% had sinus rhythm restoration during ablation. PV isolation was
demonstrated in 76% of 104 PVs treated by low peak-to-peak electrogram
amplitude (0.08±0.02 mV) inside the circular line and by
disparity in activation times (58±11 ms) across the lesion.
After 9±3 months, 22 patients (85%) were AF-free, including 62% not
taking and 23% taking antiarrhythmic drugs, with no difference
(P=NS) between paroxysmal and permanent AF. No
thromboembolic events or PV stenoses were observed by transesophageal
echocardiography.
Conclusions—Radiofrequency PV isolation with electroanatomic guidance is safe and effective in either paroxysmal or permanent AF.
Key Words: fibrillation • catheter ablation • mapping
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Atrial fibrillation (AF) is a common arrhythmia associated with significant morbidity and mortality. For many years, the only curative treatment has been surgical, with extensive atrial incisions used to compartmentalize the atrial mass below that critical for perpetuating AF.1 Recently, transcatheter linear radiofrequency (RF) ablation in the right atrium (RA) and/or left atrium (LA) has been used to replicate the surgical procedures in patients with paroxysmal or chronic AF.2 3 However, uncertainty remains concerning the requisite number of lesions, their optimal location, and the need for continuous lines. Indeed, focal ablation has been proposed as an alternative approach on the basis of the demonstration that ectopic beats originating within or at the ostium of the pulmonary veins (PVs) may be the source of paroxysmal and even persistent AF.4 5 6 Despite high acute success rates, the feasibility of this technique is limited by the difficulty in mapping the focus if the patient is in AF or has no consistent firing, the frequent existence of multiple foci causing high recurrence rates, and an incidence of PV narrowing as high as 42%.5 To circumvent these limitations, we developed an anatomic approach in which circumferential RF lesions are created around the ostia of each PV, with the aim to isolate these veins from the LA while reducing the risk of PV stenosis. A nonfluoroscopic 3D electroanatomic navigation system was used for generating and validating the continuity of circular lines. We report the feasibility, safety, and clinical outcome of this technique in patients with resistant AF, either paroxysmal or permanent.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Study Population
Patients were enrolled who had (1) paroxysmal AF, with documented daily sustained (>1 hour) episodes despite the use of antiarrhythmic drugs at therapeutic doses (number of drugs, 3±1), or (2) symptomatic permanent AF for
6 months, resistant to
pharmacological and/or electrical cardioversion (2 unsuccessful
attempts or AF recurrence within 1 month despite prophylaxis with 4±1
drugs). All patients had to be taking effective oral anticoagulation
for 4 weeks. Diagnostic workup included Holter monitoring,
transthoracic and transesophageal echocardiography, laboratory tests,
and thyroid function evaluation.
Of 26 patients selected, 14 had paroxysmal and 12 had
permanent AF, and 18 (69%) had no structural heart disease
(Table 1
). Informed consent was obtained from each patient
according to a protocol approved by the Institutional Human Research
Committee.
|
Catheter Placement
Antiarrhythmic drugs (except amiodarone) and digoxin
were discontinued for 5 half-lives. Quadripolar 6F catheters were
placed in the coronary sinus (CS), RA, and right ventricular apex. The
LA and PVs were explored through transseptal catheterization. Heparin
was titrated to maintain a partial thromboplastin time of 60 to 90
seconds.
Mapping Process
The nonfluoroscopic navigation system (CARTO;
Biosense Webster) has been described
elsewhere.2 7
With use of a special mapping and ablation catheter, 3D electroanatomic
maps are reconstructed that display the spatial distribution of local
endocardial activation times (LATs) relative to a reference
electrogram.
The navigator catheter was placed 2 to 4 cm into each PV and slowly pulled back. Along pullback, multiple locations were recorded to tag the vein. The ostium was identified by fluoroscopic visualization of the catheter tip entering the cardiac silhouette with simultaneous impedance decrease and appearance of atrial potential. Three locations were recorded along the mitral annulus to tag valve orifice. LA maps were obtained by sequentially acquiring a minimum of 50 points.
Figure 1 portrays the study protocol. In patients in sinus
rhythm (SR) at the beginning of the procedure, maps were acquired
during pacing from the CS or RA appendage at a cycle length (CL) of 600
ms
(Figure 2). Each endocardial location was recorded while a
stable catheter position was maintained, as assessed by both
end-diastolic stability (a distance <2 mm between 2 successive
locations) and LAT stability (an interval <2 ms between 2 successive
LATs). When split potentials were recorded, the LAT was derived from
the steeper of the two. For patients in AF, maps were acquired to
assess the distribution and types of electrograms by a previously
reported method.7
Local CLs were automatically analyzed and displayed as histograms,
which were classified as follows: type A, defined as fairly regular
activation with a clear isoelectric baseline; type B, irregular
activation with perturbations of baseline and/or highly fragmented
electrograms; and type C, alternation between A and B
(Figure 3). According to an anatomic
classification,8 the
LA was divided into 9 regions, listed in
Table 2. The proportion of type A, B, or C signals in each
region was computed.
|
|
|
|
Ablation Procedure
RF pulses were delivered in unipolar mode to a
cutaneous ground patch via the distal catheter electrode. Because all 4
PVs may serve as a source of
AF,4 our end point
was the creation of circumferential lines of conduction block around
each PV. These lines consisted of contiguous focal lesions deployed at
a distance 5 mm from the ostia. With a maximum temperature setting of
60°C, RF energy (up to 50 W) was applied for 60 to 120 seconds until
local electrogram amplitude was reduced by 80%. During AF, the same
power titration technique was used, but current was always delivered
for 60 to 120 seconds. If there was an impedance rise, or the patient
had cough, burning pain, or severe bradycardia, RF delivery was
stopped.
Remap Process and Lesion Validation
In patients in SR, postablation remap was performed
utilizing the preablation anatomic map for the acquisition of new
points to allow accurate comparison of pre- and post-RF activation
sequence. In patients in AF, after restoration of SR, the remap was
done with the anatomic map acquired during AF, to maintain the same
landmarks and lesion tags for reliable lesion verification. We found a
small intrapatient difference between the anatomic map of a
fibrillating, noncontracting atrium and the map during pacing, in which
locations are recorded at end diastole. This was validated by measuring
the distance between corresponding locations acquired during AF and
pacing. We tested a set of 5 points per patient in a sample of 10
patients. No differences were noted between 3 paired measurements (mean
difference 0.18±0.05 mm, t=0.74,
P=0.86).
Lesion validation required acquisition of 2 maps during CS and RA pacing for the lateral and septal PVs, respectively. The rationale behind this setting was to pace from a site close to the lesions and shorten conduction time to the ablation site, thereby allowing detection of delayed activation inside the circular line.
The following criteria were used to define line continuity:
1. Low peak-to-peak bipolar potentials (
0.1 mV) inside the
lesion, as determined by local electrogram analysis and voltage maps
(Figure 4).
|
2. LAT delay >30 ms between contiguous points lying in the
same axial plane on the external and internal sides of the line, as
assessed by activation maps
(Figure 2
). Changes in activation spread were also evaluated
with propagation maps
(Figures 5 and 6).
|
|
The presence of double potentials straddling the line was interpreted as a gap.
Postablation Management
After ablation, patients underwent 48-hour telemetry
monitoring. Nineteen patients (73%) were discharged without the need
for antiarrhythmic drugs. Of the remaining 7 (27%) patients,
amiodarone was maintained for 4 because of other arrhythmias, and 3 who
had in-hospital AF episodes were given a previously ineffective
antiarrhythmic drug. Other medications, including calcium-antagonists,
ß-blockers, and digoxin when appropriate, were prescribed to patients
who underwent electrical cardioversion and those with cardiac disease.
Oral anticoagulation was continued for 3 months.
Follow-Up
Follow-up consisted of outpatient visits with
serial echocardiograms and Holter monitoring performed on symptom
recurrence or routinely at 1 week and every month for 6 months. The
procedure was considered successful if no recurrences of AF lasting
>30 seconds were present during postdischarge follow-up.
Transesophageal echocardiography was performed within 3 days and 1 to 6
months after ablation to assess potential PV
stenosis.
Statistics
Dichotomous variables were compared by
2 tests. Log-linear techniques for
multiway contingency tables were used to compare the proportion of AF
types at different LA regions, with Bonferroni correction for pairwise
comparisons. Continuous measures are expressed as mean±SD and were
compared by ANOVA. Statistical significance was inferred at
P<0.05.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Mapping and Ablation Procedure
Preablation maps comprised 94±21 points. For AF maps, 787 sites were sampled, and 258 (33%) showed type A electrograms, 102 (13%) type B, and 427 (54%) type C. Table 2
reports spatial electrogram distribution. More than
50% of signals around the PVs (except the inferior septal vein) were
of type A.
Overall procedure duration was 290±58 minutes, and 118±16
RF pulses were deployed
(Table 3). For patients in SR, procedures lasted 247±41
minutes (range, 198 to 298 minutes) versus 327±43 minutes (range, 282
to 390 minutes) for those in AF (P<0.05), with
shorter mapping time in SR patients (60±5 versus 96±17 minutes,
P<0.05) and similar fluoroscopy time (25±3 versus
27±3 minutes, respectively; P=NS).
|
In 9 (64%) of 14 patients in AF at the beginning of the procedure, SR was acutely restored during ablation; RF was being delivered around the superior lateral PV in 6 (67%) of these 9 patients, although this was not the initial site of ablation in all but 1 patient. In 5 patients who were still in AF after completion of ablation, the arrhythmia was terminated by direct current shocks.
After ablation, among 104 PVs treated, complete isolation
was demonstrated by absence of discrete electrical activity (voltage
0.1 mV) at all sites inside the lesion in 79 (76%)
(Table 4). Such lesions were associated with marked LAT
delay (58±11 ms). Incomplete lesions were dichotomized into those with
LAT delay >30 ms (11/104 [11%], including 2 superior septal, 6
inferior septal, and 3 inferior lateral PVs) and those without delay
(14/104 [13%], including 8 inferior septal and 6 inferior lateral
PVs). Interestingly, incomplete lesions without delay were associated
with significant LAT prolongation and amplitude decrease versus pre-RF
signals.
|
Clinical Outcome
No patient developed intolerable pain or severe cough
during RF delivery. One patient (4%) who had hemopericardium recovered
well after pericardiocentesis. There were no strokes or other
thromboembolic events. Two patients had mild pericardial effusion
managed medically. During the first 48 hours from ablation, 3 patients
(12%) developed spontaneously terminating AF episodes lasting from 7
minutes to 2 hours. All patients were discharged in SR. In patients
with paroxysmal AF, predischarge echocardiography demonstrated
unchanged LA transport function (peak A-wave velocity 0.54±0.06 m/s
before RF versus 0.51±0.07 m/s after RF; P=NS). Of
the 12 patients with permanent AF, mitral A waves were detectable in
all patients who returned to SR during ablation and in only 1 of the 5
who were defibrillated (peak A velocity 0.37±0.12 m/s). During
follow-up, all patients without AF recurrence showed preserved LA
contraction, with mitral inflow tracings demonstrating progressive
improvement (peak A velocity 0.60±0.09 m/s, P<0.05
versus early post-RF). Transesophageal echocardiography showed no
high-velocity turbulence near the ostia that suggested PV stenosis in
any of the patients (peak flow velocities [m/s]: pre-RF, 0.59±0.10;
post-RF, 0.65±0.13; follow-up, 0.62±0.09; P=NS for
all comparisons).
After 9±3 months of follow-up, 22 patients (85%) had
stable SR, including 16 (62%) who were no longer taking antiarrhythmic
drugs and 6 (23%) who were still taking drugs
(Table 3). Overall freedom from AF was not dissimilar
(P=NS) for paroxysmal AF (12/14 patients [86%],
including 7 not taking antiarrhythmic drugs) and permanent AF (10/12
patients [83%], including 9 not taking drugs). AF recurred in 4
patients (15%): 2 ablated for paroxysmal AF developed brief (<1 hour)
and rare (<3 per month) episodes, and 2 who had permanent AF developed
sustained episodes responsive to drugs. There was no difference between
patients with and without recurrence in the number of PVs with
incomplete lines (6/16 veins [38%] in patients with recurrence
versus 19/88 veins [22%] in those without recurrence,
P=NS).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
This study describes a new ablative technique for curing AF by creating circumferential lesions around the PV ostia based on an anatomic map. This approach appears more feasible than CARTO-guided LA compartmentalization through a single long line encircling the PVs altogether and connected to the mitral annulus by a curvilinear line along the lateral LA wall. Difficulties in deploying such complex lesions result in long procedural times (up to 10 hours) and extensive use of fluoroscopy.2 9 In the present study, procedures for patients in SR lasted
250
minutes, significantly less than for patients in AF, with very short
fluoroscopic times in both groups. Thus, in a routine setting, when one
may not acquire detailed AF maps and patients may even be cardioverted
before ablation, procedural times are quite satisfactory. Development
of new catheter designs allowing generation of ring lesions at PV ostia
with a single application will further improve the feasibility of our
approach.
Electrophysiological Evidence of Lesion
Completeness
Unlike linear lesions, a circular line of block around
an isolated tube such as a PV should result in no discrete local
electrical activity beyond the line. With this criterion, PV isolation
was demonstrated by voltage maps in 76% of the veins treated. For such
lesions, however, visualization of entry, albeit delayed, into the
ablated area (activation and propagation maps) is in apparent contrast
with the existence of complete conduction block. In this case, either
the lesion is not truly complete or the CARTO system, which is able to
sense amplitudes as low as 10-3mV, is
recording far-field electrical activity.
Interestingly, 11% of the lesions did not meet the voltage criterion but had a significant conduction delay. This suggests that the empiric rules regarding what constitutes an adequate amount of delay to denote a complete line are particularly difficult to define for a circumferential lesion. In addition, even lesions that did not satisfy both the activation delay and voltage criteria were associated with significant changes in the activation sequence and amplitude compared with preablation. This is noteworthy because such lesions may have produced enough atrial injury to achieve a therapeutic effect, as suggested by the lack of relationship between lesion completeness and AF recurrence in the present study.
Safety
RF applications around the PV orifices were well
tolerated. The rate of important pericardial effusion (4%) was similar
to that in previous transseptal
studies.3 5 9
We had no cases of PV stenosis, probably because lesions were deployed
5 mm apart from the ostia, thereby avoiding scarring and contraction
of the venous wall resulting from thermal injury.
Clinical Outcome
The rate of in-hospital AF episodes was 12% in the
present study, lower than that occurring after surgical maze procedure
(47%) or linear ablation (63%), probably because of lesser lesion
extent.1 2
After a mean follow-up of 9 months, 85% of the patients were free of
AF, with 62% no longer taking antiarrhythmic drugs (true success rate)
and 23% taking drugs that had been ineffective before ablation. These
results are better than those obtained with CARTO-guided linear LA
ablation alone and comparable to those of biatrial ablation in
paroxysmal AF,2 and
they appear satisfactory especially considering that RA triggers were
not weighed and that "complete" block was obtained only in two
thirds of veins.
Our finding of similar outcomes in paroxysmal and permanent AF raises important issues as to which is the mechanism underlying the efficacy of PV isolation. During AF in our patients, the areas around the PVs predominantly showed organized atrial electrograms, in keeping with previous studies using multielectrode mapping systems.3 10 Such regular electrogram patterns have been shown to correlate closely with the shortest atrial effective refractory periods, which, in turn, represent an important determinant of AF persistence.11 Thus, our anatomy-based RF lesions may have altered AF arrhythmogenic substrate, as also suggested by the acute SR restoration during ablation in 64% of patients. This interpretation is further supported by a study showing termination of chronic AF with ablation that targeted sites of organized activity adjacent to PV openings.3
Alternatively, PV isolation might have interrupted pathways crucial in the genesis of AF located at the PV-LA junction. This hypothesis is consistent with experimental studies showing that ablation of the ligament of Marshall (which is adjacent to the superior lateral PV) can prevent isoproterenol-induced AF in dogs12 and that PV isolation alone without maze procedure can eliminate chronic AF in a sheep model.13 At the same time, electrical disconnection of all 4 PVs at their ostia may block the egress of potential AF triggers arising from within the veins.4 5 6 The lack of correlation between AF recurrence and achievement of complete lines of block may be due to the fact that the discontinuous lines involved mainly the inferior PVs, which contain less-developed myocardial sleeves and have less-frequent ectopic potentials than the superior veins.4 5 8 Finally, atrial debulking and/or denervation may have contributed to suppression of AF.14
Study Limitations
The complexity of this technique should not be
underestimated. Our results have been obtained at a center with
extensive experience in performing CARTO-guided atrial ablation (>500
procedures in the last 2 years). For this approach to be used safely,
detailed institutional protocols are needed, including special staff
training, expert monitoring of the patients, and careful outcome
assessment.
Insight into the mechanism of AF is limited by the lack of RA mapping and the fact that only qualitative assessment of electrogram types was performed.
Although 89% to 94% of AF triggers have been shown in the PVs, the arrhythmia can be initiated by ectopy from the crista terminalis, CS ostium, and atrial free wall.4 5 Therefore, a limitation to a purely anatomic map is that a complex PV isolation procedure can be performed, yet the source of AF may not be the PVs. However, ablation may still be effective through mechanisms other than isolation of PV foci.
Our population was predominantly composed of young patients who had no structural heart disease, normal LA size, and good cardiac function. This clinical profile is commonly associated with resistant AF and a high likelihood of a focal source.4 5 6 Whether our results can be extrapolated to a broader AF population is unknown.
Conclusions
This study lends further evidence to the concept of the
dominance of the LA in the region of the PVs in the initiation and/or
maintenance of AF. The efficacy of PV isolation in both paroxysmal and
permanent AF supports the current notion of a common pathogenesis
(involving various combinations of focal activity and reentry) with a
spectrum of clinical presentations. On the basis of our findings, one
can envision that PV isolation may be proposed as a valuable
alternative to either focal ablation or biatrial
compartmentalization.
Received April 5, 2000; revision received June 12, 2000; accepted July 7, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Cox JL, Boineau JP, Schuessler RB, et al. Five year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg. 1993;56:814–823.[Abstract]
2.
Pappone
C, Oreto G, Lamberti F, et al. Catheter ablation of paroxysmal atrial
fibrillation using a 3D mapping system. Circulation. 1999;100:1203–1208.
3. Maloney JD, Milner L, Barold S, et al. Two staged biatrial linear and focal ablation to restore sinus rhythm in patients with refractory chronic atrial fibrillation. Pacing Clin Electrophysiol. 1998;21:2527–2532.[Medline] [Order article via Infotrieve]
4.
Haïssaguerre
M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial
fibrillation by ectopic beats originating in the pulmonary veins.
N Engl J Med. 1998;339:659–666.
5.
Chen SA,
Hsieh MH, Tai TC, et al. Initiation of atrial fibrillation by ectopic
beats originating from the pulmonary veins.
Circulation. 1999;100:1879–1866.
6. Hobbs WJ, Van Gelder IC, Fitzpatrick AP, et al. The role of atrial electrical remodeling in the progression of focal atrial ectopy to persistent atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:866–870.[Medline] [Order article via Infotrieve]
7. Kuck KE, Ernst S, Cappato R, et al. Nonfluoroscopic endocardial catheter mapping of atrial fibrillation. J Cardiovasc Electrophysiol. 1998;9:S57–S62.[Medline] [Order article via Infotrieve]
8. Yen H S, Sanchez-Quintana D, Cabrera JA, et al. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:1525–1533.[Medline] [Order article via Infotrieve]
9.
Ernst S,
Schluter M, Ouyang F, et al. Modification of the substrate for
maintenance of idiopathic human atrial fibrillation.
Circulation. 1999;100:2085–2092.
10.
Harada
A, Sasaki K, Fukushima T, et al. Atrial activation during chronic
atrial fibrillation in patients with isolated mitral valve disease.
Ann Thorac Surg. 1996;61:104–112.
11. Li H, Hare J, Mughal K, et al. Distribution of atrial electrograms during atrial fibrillation: effect of rapid atrial pacing and intercaval junction ablation. J Am Coll Cardiol. 1996;27:1713–1721.[Abstract]
12.
Doshi
RN, Wu TJ, Yashima M, et al. Relation between ligament of Marshall and
adrenergic atrial tachycardia. Circulation. 1999;100:876–883.
13. Fieguth HG, Wahlers T, Borst HG. Inhibition of atrial fibrillation by pulmonary vein isolation and auricular resection: experimental study in a sheep model. Eur J Cardiothorac Surg. 1997;11:714–721.[Abstract]
14.
Elvan
A, Pride HP, Eble JN, et al. Radiofrequency catheter ablation of the
atria reduces inducibility and duration of atrial fibrillation in dogs.
Circulation. 1995;91:2235–2244.
This article has been cited by other articles:
 |
|
 |
|
  J. W. Schrickel, L. Lickfett, T. Lewalter, E. Mittman-Braun, S. Selbach, K. Strach, C. P. Nahle, J. O. Schwab, M. Linhart, R. Andrie, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation Europace, January 1, 2010; 12(1): 52 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Harata, Y. Inden, M. Shimano, T. Uchikawa, M. Mutoh, M. Hirai, and T. Murohara Morphological characteristics of the Holter P-waves associated with pulmonary vein pacing Europace, January 1, 2010; 12(1): 124 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Klinkenberg, S. Ahmed, A. T. Hagen, A. C.P. Wiesfeld, E. S. Tan, F. Zijlstra, and I. C. Van Gelder Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation using minimal invasive surgery and high intensity focused ultrasound Europace, December 1, 2009; 11(12): 1624 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamada, N. Yoshida, Y. Murakami, T. Okada, Y. Yoshida, M. Muto, Y. Inden, and T. Murohara The difference in autonomic denervation and its effect on atrial fibrillation recurrence between the standard segmental and circumferential pulmonary vein isolation techniques Europace, December 1, 2009; 11(12): 1612 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dizon, K. Chen, M. Bacchetta, M. Argenziano, D. Mancini, A. Biviano, J. Sonett, and H. Garan A Comparison of Atrial Arrhythmias After Heart or Double-Lung Transplantation at a Single Center Insights Into the Mechanism of Post-Operative Atrial Fibrillation. J. Am. Coll. Cardiol., November 24, 2009; 54(22): 2043 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bertaglia, C. Tondo, A. De Simone, F. Zoppo, M. Mantica, P. Turco, A. Iuliano, G. Forleo, V. La Rocca, and G. Stabile Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience Europace, November 3, 2009; (2009) eup349v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X Wang, X Liu, H Shi, J Gu, Y Sun, L Zhou, and W Hu Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases Heart, November 1, 2009; 95(21): 1773 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Shah Electrophysiological evaluation of pulmonary vein isolation Europace, November 1, 2009; 11(11): 1423 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Khaykin, A. Skanes, J. Champagne, S. Themistoclakis, L. Gula, A. Rossillo, A. Bonso, A. Raviele, C. A. Morillo, A. Verma, et al. A Randomized Controlled Trial of the Efficacy and Safety of Electroanatomic Circumferential Pulmonary Vein Ablation Supplemented by Ablation of Complex Fractionated Atrial Electrograms Versus Potential-Guided Pulmonary Vein Antrum Isolation Guided by Intracardiac Ultrasound Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 481 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kapa and S. J. Asirvatham Atrial Fibrillation: Focal or Reentrant or Both?: A New Autonomic Lens to Examine an Old Riddle Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 345 - 348. [Full Text] [PDF]
|
|
|
|
|
|
J Pontoppidan, J C Nielsen, S H Poulsen, H K Jensen, H Walfridsson, A K Pedersen, and P S Hansen Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial Heart, June 15, 2009; 95(12): 994 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sohara, H. Takeda, H. Ueno, T. Oda, and S. Satake Feasibility of the Radiofrequency Hot Balloon Catheter for Isolation of the Posterior Left Atrium and Pulmonary Veins for the Treatment of Atrial Fibrillation Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Belhassen A 1 per 1,000 mortality rate after catheter ablation of atrial fibrillation an acceptable risk? J. Am. Coll. Cardiol., May 12, 2009; 53(19): 1804 - 1806. [Full Text] [PDF]
|
|
|
|
|
|
K. Rajappan, V. Baker, L. Richmond, P. M. Kistler, G. Thomas, C. Redpath, S. C. Sporton, M. J. Earley, S. Harris, and R. J. Schilling A randomized trial to compare atrial fibrillation ablation using a steerable vs. a non-steerable sheath Europace, May 1, 2009; 11(5): 571 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Holmes Jr, K. H. Monahan, and D. Packer Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation: Clinical Spectrum and Interventional Considerations J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 267 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Peters, J. V. Wylie, T. H. Hauser, R. Nezafat, Y. Han, J. J. Woo, J. Taclas, K. V. Kissinger, B. Goddu, M. E. Josephson, et al. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement a pilot study. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 308 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pandit and N. F. Marrouche Cardiac magnetic resonance in the world of the cardiac electrophysiologist the road to real-time cardiac magnetic resonance. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 317 - 318. [Full Text] [PDF]
|
|
|
|
|
|
N Perez-Castellano, J Villacastin, J Salinas, J Moreno, M Doblado, E Ruiz, R Isa, and C Macaya Cooled ablation reduces pulmonary vein isolation time: results of a prospective randomised trial Heart, February 1, 2009; 95(3): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Andrikopoulos, S. Tzeis, N. Maniadakis, H. E. Mavrakis, and P. E. Vardas Cost-effectiveness of atrial fibrillation catheter ablation Europace, February 1, 2009; 11(2): 147 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jais, B. Cauchemez, L. Macle, E. Daoud, P. Khairy, R. Subbiah, M. Hocini, F. Extramiana, F. Sacher, P. Bordachar, et al. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study Circulation, December 9, 2008; 118(24): 2498 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kistler, K. Rajappan, S. Harris, M. J. Earley, L. Richmond, S. C. Sporton, and R. J. Schilling The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study Eur. Heart J., December 2, 2008; 29(24): 3029 - 3036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H.M. Wittkampf Image integration in 3D catheter mapping systems: proof of the pudding Eur. Heart J., December 2, 2008; 29(24): 2957 - 2958. [Full Text] [PDF]
|
|
|
|
|
|
T. H. Hauser, D. C. Peters, J. V. Wylie, and W. J. Manning Evaluating the left atrium by magnetic resonance imaging Europace, November 1, 2008; 10(suppl_3): iii22 - iii27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Halperin and S. Nazarian Damage Assessment After Ablation: Role of Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1272 - 1273. [Full Text] [PDF]
|
|
|
|
|
|
F. Gaita, D. Caponi, M. Scaglione, A. Montefusco, A. Corleto, F. Di Monte, D. Coin, P. Di Donna, and C. Giustetto Long-Term Clinical Results of 2 Different Ablation Strategies in Patients With Paroxysmal and Persistent Atrial Fibrillation Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 269 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Blaauw and H J G M Crijns Treatment of atrial fibrillation Heart, October 1, 2008; 94(10): 1342 - 1349. [Full Text] [PDF]
|
|
|
|
|
|
A. Proclemer, G. Allocca, D. Gregori, C. Bonanno, R. Ometto, A. Fontanelli, R. Mantovan, M. Crosato, V. Calzolari, D. Pavoni, et al. Radiofrequency ablation of drug-refractory atrial fibrillation: an observational study comparing 'ablate and pace' with pulmonary vein isolation Europace, September 1, 2008; 10(9): 1085 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Aliot and J. N. Ruskin Controversies in ablation of atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H32 - H54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Knecht, H. Skali, M. D. O'Neill, M. Wright, S. Matsuo, G. M. Chaudhry, C. I. Haffajee, I. Nault, G. H.M. Gijsbers, F. Sacher, et al. Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia Europace, August 1, 2008; 10(8): 931 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matiello, L. Mont, D. Tamborero, A. Berruezo, B. Benito, E. Gonzalez, and J. Brugada Cooled-tip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: comparison of efficacy, safety, and lesion extension Europace, August 1, 2008; 10(8): 955 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pokushalov, A. Turov, P. Shugayev, S. Artyomenko, A. Romanov, and N. Shirokova Catheter Ablation of Left Atrial Ganglionated Plexi for Atrial Fibrillation Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hertervig, O. Kongstad, E. Ljungstrom, B. Olsson, and S. Yuan Pulmonary vein potentials in patients with and without atrial fibrillation Europace, June 1, 2008; 10(6): 692 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Wang, X. Liu, Y.-M. Sun, H.-F. Shi, L. Zhou, and J.-N. Gu Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study Europace, May 1, 2008; 10(5): 600 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A Lubitz, A. Fischer, and V. Fuster Catheter ablation for atrial fibrillation BMJ, April 12, 2008; 336(7648): 819 - 826. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Patel, A. d'Avila, P. Neuzil, S. J. Kim, MSEE, T. Mela, J. P. Singh, J. N. Ruskin, and V. Y. Reddy Atrial Tachycardia After Ablation of Persistent Atrial Fibrillation: Identification of the Critical Isthmus With a Combination of Multielectrode Activation Mapping and Targeted Entrainment Mapping Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 14 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Wellens Forty Years of Invasive Clinical Electrophysiology: 1967-2007 Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 49 - 53. [Full Text] [PDF]
|
|
|
|
|
|
T. R. Betts Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients Europace, April 1, 2008; 10(4): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, M. K. Off, E. Solheim, P. Schuster, P. I. Hoff, and O.-J. Ohm Treatment of atrial fibrillation by silencing electrical activity in the posterior inter-pulmonary-vein atrium Europace, March 1, 2008; 10(3): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pratola, E. Baldo, P. Notarstefano, T. Toselli, and R. Ferrari Radiofrequency Ablation of Atrial Fibrillation: Is the Persistence of All Intraprocedural Targets Necessary for Long-Term Maintenance of Sinus Rhythm? Circulation, January 15, 2008; 117(2): 136 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Marine Catheter Ablation Therapy for Supraventricular Arrhythmias JAMA, December 19, 2007; 298(23): 2768 - 2778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sutton, J. D. Fisher, C. Linde, and D. G. Benditt History of electrical therapy for the heart Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I3 - I10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pappone and V. Santinelli Non-fluoroscopic mapping as a guide for atrial ablation: current status and expectations for the future Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I36 - I47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Seow, T.-W. Lim, C.-H. Koay, D. L. Ross, and S. P. Thomas Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation Europace, December 1, 2007; 9(12): 1129 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Arrantes, F. Gaita, K.-t. Lim, M. Scaglione, P. Jais, M. Hocini, S. Matsuo, S. Knecht, and M. Haissaguerre Atrial fibrillation ablation: evolution of the curative approach Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I129 - I135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Saremi and S. Krishnan Cardiac Conduction System: Anatomic Landmarks Relevant to Interventional Electrophysiologic Techniques Demonstrated with 64-Detector CT RadioGraphics, November 1, 2007; 27(6): 1539 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Schneeberger and R. M. Osterday Lateral Placement of Bipolar Clamp Facilitates Pulmonary Vein Isolation Ann. Thorac. Surg., October 1, 2007; 84(4): 1412 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. O'Neill, P. Jais, M. Hocini, F. Sacher, G. J. Klein, J. Clementy, and M. Haissaguerre Catheter Ablation for Atrial Fibrillation Circulation, September 25, 2007; 116(13): 1515 - 1523. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Ulphani, R. Arora, J. H. Cain, R. Villuendas, S. Shen, D. Gordon, F. Inderyas, L. A. Harvey, A. Morris, J. J. Goldberger, et al. The ligament of Marshall as a parasympathetic conduit Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1629 - H1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Lindsay Is Pulmonary Vein Antrum Isolation a Critical Determinant of Recurrent Arrhythmias After Ablation of Atrial Fibrillation? J. Am. Coll. Cardiol., August 28, 2007; 50(9): 875 - 876. [Full Text] [PDF]
|
|
|
|
|
|
G. B. Forleo, C. Tondo, L. De Luca, A. D. Russo, M. Casella, V. De Sanctis, F. Clementi, R. L. Fagundes, R. Leo, F. Romeo, et al. Gender-related differences in catheter ablation of atrial fibrillation Europace, August 1, 2007; 9(8): 613 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Arentz, R. Weber, G. Burkle, C. Herrera, T. Blum, J. Stockinger, J. Minners, F. J. Neumann, and D. Kalusche Small or Large Isolation Areas Around the Pulmonary Veins for the Treatment of Atrial Fibrillation?: Results From a Prospective Randomized Study Circulation, June 19, 2007; 115(24): 3057 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF]
|
|
|
|
|
|
K. Nademanee Trials and Travails of Electrogram-Guided Ablation of Chronic Atrial Fibrillation Circulation, May 22, 2007; 115(20): 2592 - 2594. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Kanj, O. Wazni, T. Fahmy, S. Thal, D. Patel, C. Elay, L. Di Biase, M. Arruda, W. Saliba, R. A. Schweikert, et al. Pulmonary Vein Antral Isolation Using an Open Irrigation Ablation Catheter for the Treatment of Atrial Fibrillation: A Randomized Pilot Study J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1634 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Peters, J. V. Wylie, T. H. Hauser, K. V. Kissinger, R. M. Botnar, V. Essebag, M. E. Josephson, and W. J. Manning Detection of Pulmonary Vein and Left Atrial Scar after Catheter Ablation with Three-dimensional Navigator-gated Delayed Enhancement MR Imaging: Initial Experience Radiology, March 1, 2007; 243(3): 690 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Wazni, H.-M. Tsao, S.-A. Chen, H.-H. Chuang, W. Saliba, A. Natale, and A. L. Klein Cardiovascular Imaging in the Management of Atrial Fibrillation J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2077 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nilsson, X. Chen, S. Pehrson, and J. H. Svendsen The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation. Europace, November 1, 2006; 8(11): 962 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Coutu, D. Chartier, and S. Nattel Comparison of Ca2+-handling properties of canine pulmonary vein and left atrial cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2290 - H2300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]
|
|
|
|
|
|
M. Scanavacca, C. F. Pisani, D. Hachul, S. Lara, C. Hardy, F. Darrieux, I. Trombetta, C. E. Negrao, and E. Sosa Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation Circulation, August 29, 2006; 114(9): 876 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): 700 - 752. [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF]
|
|
|
|
|
|
I. Deisenhofer, H. Estner, B. Zrenner, J. Schreieck, S. Weyerbrock, G. Hessling, K. Scharf, M. R. Karch, and C. Schmitt Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation. Europace, August 1, 2006; 8(8): 573 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm Current strategies in the management of atrial fibrillation. Ann. Thorac. Surg., July 1, 2006; 82(1): 357 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E.W. Hemels, Y. L. Gu, A. E. Tuinenburg, P. W. Boonstra, A. C.P. Wiesfeld, M. P. van den Berg, D. J. Van Veldhuisen, and I. C. Van Gelder Favorable long-term outcome of maze surgery in patients with lone atrial fibrillation. Ann. Thorac. Surg., May 1, 2006; 81(5): 1773 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pappone, G. Vicedomini, F. Manguso, F. Gugliotta, P. Mazzone, S. Gulletta, N. Sora, S. Sala, A. Marzi, G. Augello, et al. Robotic Magnetic Navigation for Atrial Fibrillation Ablation J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1390 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Forlani, R. De Paulis, L. G. Wolf, R. Greco, P. Polisca, M. Moscarelli, and L. Chiariello Conversion to Sinus Rhythm by Ablation Improves Quality of Life in Patients Submitted to Mitral Valve Surgery Ann. Thorac. Surg., March 1, 2006; 81(3): 863 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M C S Hall and D M Todd Modern management of arrhythmias Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dickfeld, R. Kato, M. Zviman, S. Lai, G. Meininger, A. C. Lardo, A. Roguin, D. Blumke, R. Berger, H. Calkins, et al. Characterization of Radiofrequency Ablation Lesions With Gadolinium-Enhanced Cardiovascular Magnetic Resonance Imaging J. Am. Coll. Cardiol., January 17, 2006; 47(2): 370 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A de Roos, L J M Kroft, J J Bax, H J Lamb, and J Geleijns Cardiac applications of multislice computed tomography Br. J. Radiol., January 1, 2006; 79(937): 9 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sra, D. Krum, A. Malloy, M. Vass, B. Belanger, E. Soubelet, R. Vaillant, and M. Akhtar Registration of Three-Dimensional Left Atrial Computed Tomographic Images With Projection Images Obtained Using Fluoroscopy Circulation, December 13, 2005; 112(24): 3763 - 3768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Essebag, F. Baldessin, M. R. Reynolds, S. McClennen, J. Shah, K. F. Kwaku, P. Zimetbaum, and M. E. Josephson Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation Eur. Heart J., December 1, 2005; 26(23): 2550 - 2555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F R Quinn and A C Rankin Atrial fibrillation ablation in the real world Heart, December 1, 2005; 91(12): 1507 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. Beukema, A. Elvan, H. T. Sie, A. R. Ramdat Misier, and H. J.J. Wellens Successful Radiofrequency Ablation in Patients With Previous Atrial Fibrillation Results in a Significant Decrease in Left Atrial Size Circulation, October 4, 2005; 112(14): 2089 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Padanilam and E. N. Prystowsky Should Ablation Be First-Line Therapy and for Whom: The Antagonist Position Circulation, August 23, 2005; 112(8): 1223 - 1231. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Edelson, R. Shah, and D. Ost A 45-Year-Old Man With Left Lung Hypoperfusion and Possible Pulmonary Embolism Chest, August 1, 2005; 128(2): 1032 - 1036. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||